Vimarsana
Biggest News Aggregation in the World

Reverse Phase Protein Array News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reverse Phase Protein Array. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reverse Phase Protein Array Today - Breaking & Trending Today

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates - Vimarsana News

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

Published: December 18, 2023

Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 -- Theralink Technologies , a precision oncology company with an exclusively licensed commercial RPPA technology platform, is excited to...

Source: marketscreener.com
Related Topics:
United StatesSan FranciscoTrevor MccartneyEmanuelf PetricoinGlobenewswire IncUniversity ProfessorUniversity Of CaliforniaGeorge Mason UniversityTheralink Technologies IncSecurities ExchangeMason Science School Of Systems BiologyExchange CommissionMason UniversityCell Reports MedicineResponse Predictive SignatureTriple Negative Breast CancerApplied ProteomicsMolecular MedicineBreast CancerDistinguished University ProfessorScience SchoolReverse Phase Protein ArraySecurities ActSecurities Exchange ActMerger Agreement
Theralink® and IMAC Holdings announce receipt and response - Vimarsana News

Theralink® and IMAC Holdings announce receipt and response

Published: November 13, 2023

Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision...

Source: globenewswire.com
Related Topics:
United StatesTrevor MccartneyExchange CommissionTheralink Technologies IncHoldings IncSecurities ExchangeChief Executive OfficerFaith ZaslavskyTheralink TechnologiesReverse Phase Protein ArraySecurities ActSecurities Exchange ActMerger AgreementQuarterly ReportsCurrent ReportsAnnual ReportsOther Otc TherTheralink TechnologiesTc TherExchange CommissionDa Approved Drug
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board -November 03, 2023 at 09:16 am EDT - Vimarsana News

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board -November 03, 2023 at 09:16 am EDT

Published: November 3, 2023

Golden, Colorado, Nov. 03, 2023 -- Theralink Technologies, Inc. , a precision oncology company with its exclusive commercial RPPA technology that can help predict which FDA-approved drug is...

Source: marketscreener.com
Related Topics:
United StatesTrevor MccartneyExchange CommissionInova Schar Cancer InstituteGastrointestinal Cancer ProgramSecurities ExchangeHoldings IncTheralink Technologies IncGlobenewswire IncSchar Cancer InstituteMolecular Tumor BoardInova Schar Molecular TumorSchar CancerChief Executive OfficerInova Molecular Tumor BoardReverse Phase Protein ArraySecurities ActSecurities Exchange ActMerger AgreementQuarterly ReportsCurrent ReportsAnnual ReportsMulti Omic DataMolecular Tumor Board RevealsInhibitor Resistance
IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market - Vimarsana News

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

Published: July 26, 2023

Franklin, Tennessee, July 26, 2023 -- IMAC Holdings, Inc. , a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced...

Source: marketscreener.com
Related Topics:
United StatesTheralink Technologies IncTechnologies IncHoldings IncGlobenewswire IncJoseph Gunnar CoExchange CommissionTheralink TechnologiesPreferred StockSecurities ActReverse Phase Protein Array
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company - Vimarsana News

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

Published: May 23, 2023

Theralink's patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict which FDA-approved drugs may be effective in each... | May 23, 2023

Source: marketscreener.com
Related Topics:
United StatesJeffrey BuschMick RuxinExchange CommissionSecurities ExchangeHoldings IncTheralink Technologies IncJoseph Gunnar CoOlshan Frome WoloskyTheralink TechnologiesAdvanced Breast CancerReverse Phase Protein ArrayAdditional InformationRegistration StatementAnnual ReportSecurities ActSecurities Exchange ActMerger AgreementQuarterly ReportsCurrent ReportsAnnual ReportsImac HoldingsNc Stock ExchangePress ReleaseN Back Us44967k1043